Cargando…
Anandamide inhibits breast tumor-induced angiogenesis
Breast cancer is one of the most frequently diagnosed malignancies and a leading cause of cancer death in women. Great advances in the treatment of primary tumors have led to a significant increment in the overall survival rates, however recurrence and metastatic disease, the underlying cause of dea...
Autores principales: | Picardi, P, Ciaglia, E, Proto, MC, Pisanti, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Universitài Salerno
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140423/ https://www.ncbi.nlm.nih.gov/pubmed/25147760 |
Ejemplares similares
-
Role of FAAH-Like Anandamide Transporter in Anandamide Inactivation
por: Leung, KwanNok, et al.
Publicado: (2013) -
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
por: Ciaglia, Elena, et al.
Publicado: (2015) -
Inhibition by Anandamide of 6-Hydroxydopamine-Induced Cell Death in PC12 Cells
por: Mnich, Katarzyna, et al.
Publicado: (2010) -
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries
por: Stanley, Christopher P., et al.
Publicado: (2016) -
Anandamide uptake by synaptosomes from human, mouse and rat brain: inhibition by glutamine and glutamate
por: Battista, Natalia, et al.
Publicado: (2002)